EMEA-000383-PIP04-23 - paediatric investigation plan
Cladribine
PIPHuman
Key facts
- Active Substance
- Cladribine
- Therapeutic area
- Nervous system disorders
- Decision number
- P/0009/2024
- PIP number
- EMEA-000383-PIP04-23
- Pharmaceutical form(s)
- All pharmaceutical forms
- Condition(s) / indication(s)
- Treatment of myasthenia gravis
- Route(s) of administration
- All routes of administration
- Contact for public enquiries
Merck Europe B.V.
Tel.: +49 6151725200
E-mail: service@merckgroup.com- Decision type
- W: decision granting a waiver in all age groups for all conditions or indications
- Decision date